Abstract
In this retrospective study, we conducted a clinico-genetic analysis of patients with autosomal recessive limb-girdle muscular dystrophy (LGMD) and Miyoshi muscular dystrophy (MMD). Patients were identified at the tertiary referral centre for DNA diagnosis in the Netherlands and included if they carried two mutations in CAPN3, DYSF, SGCG, SGCA, SGCB, SGCD, TRIM32, FKRP or ANO5 gene. DNA was screened by direct sequencing and multiplex ligand-dependent probe amplification (MLPA) analysis. A total of 244 patients was identified; 68 LGMDR1/LGMD2A patients with CAPN3 mutations (28%), 67 sarcoglycanopathy patients (LGMDR3-5/LGMD2C-E) (27%), 64 LGMDR12/LGMD2L and MMD3 patients with ANO5 mutations (26%), 25 LGMDR2/LGMD2B and MMD1 with DYSF mutations (10%), 21 LGMDR9/LGMD2I with FKRP mutations (9%) and one LGMDR8/LGMD2H patient with TRIM32 mutations (
Original language | English |
---|---|
Pages (from-to) | 126-133 |
Number of pages | 8 |
Journal | Clinical Genetics |
Volume | 96 |
Issue number | 2 |
DOIs | |
Publication status | Published - Aug-2019 |
Keywords
- limb-girdle muscular dystrophy
- Miyoshi muscular dystrophy
- neurology
- neuromuscular disorders
- ANOCTAMIN 5
- DUTCH PATIENTS
- FOLLOW-UP
- PREVALENCE
- MUTATIONS
- DIAGNOSIS
- COHORT
- GUIDELINE
- PHENOTYPE
- FREQUENCY